Calsada Crispina

Chief Financial Officer at Regulus Therapeutics Inc.

Sold, on record
$62k
Dollars the filings state
Form 4 sales
2
Latest Jan 14, 2025
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Regulus Therapeutics Inc.Unusual
    Jan 18, 2024 2024

    Sold 5,468 shares at $1.19 ($7k)

    Calsada Crispina, Chief Financial Officer

    No 10b5-1 planSold 48.6% of holdings ($13k position)5,782 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Regulus Therapeutics Inc.Routine
    Jan 14, 2025 +362 days

    Sold 43,804 shares at $1.26 ($55k)

    Calsada Crispina, Chief Financial Officer

    10b5-1 planSold 49.1% of holdings ($112k position)45,478 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Calsada Crispina
Source
Jan 14, 2025Jan 15, 2025Regulus Therapeutics Inc.Chief Financial OfficerForm 4 sale43,804$55k49.1%RoutineSEC
Jan 18, 2024Jan 18, 2024Regulus Therapeutics Inc.Chief Financial OfficerForm 4 sale5,468$7k48.6%UnusualSEC